L Stock Recent News

NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) will report third quarter 2024 financial results on Monday, November 4, 2024. On that date the Company will also post earnings remarks on its website.

Basel, 13 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq HybrezaTM (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for subcutaneous (SC), under the skin injection for patients in the United States. Tecentriq Hybreza can be injected subcutaneously over approximately seven minutes, compared with 30-60 minutes for standard intravenous (IV) infusion of Tecentriq (atezolizumab).2 It will be available for all IV indications of Tecentriq approved for adults in the U.S., including certain types of lung, liver, skin and soft tissue cancer.3

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq Hybreza™ (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for subcutaneous (SC), under the skin injection for patients in the United States. Tecentriq Hybreza can be injected subcutaneously over approximately seven minutes, compared with 30-60 minutes for standard IV i.

NEW YORK , Sept. 9, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today that the Delaware Court of Chancery found no liability in connection with Loews's 2018 acquisition of the minority limited partner interests in its Boardwalk Pipelines subsidiary.

NEW YORK , Aug. 6, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today the declaration of the Company's quarterly dividend of $0.0625 per share of Common Stock, payable September 3, 2024 to shareholders of record as of the close of business on August 21, 2024. Loews Corporation is a diversified company with businesses in the insurance, energy, hospitality, and packaging industries.

I'm a big fan of Berkshire Hathaway (NYSE: BRK-A , BRK-B ) and Warren Buffett. As a result, I've become a big fan of holding company stocks.

Loews said on Monday that James Tisch will hand over the CEO role to his son after 25 years at the helm. The company also reported a 2.5% jump in its quarterly profit, helped by a rise in insurance premiums and higher returns on its investments.

Loblaw (TSX:L) and its parent company George Weston have agreed to pay $500 million to settle a class action lawsuit regarding the grocery chain's involvement in bread price-fixing. The plaintiffs alleged that between 2001 and 2015, a group of companies including Loblaws and the Weston companies, Metro, Walmart Canada, Giant Tiger and Sobeys and its owner Empire Company Limited engaged in a price-fixing conspiracy which artificially raised the prices of packaged bread.

NEW YORK, July 9, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) will report second quarter 2024 financial results on Monday, July 29, 2024. On that date the Company will also post earnings remarks on its website.

Jonathan Tisch, Loews Hotels executive chairman and New York Giants co-owner, joins 'Squawk on the Street' to discuss the executive chairman's thoughts on consumer spending, the company's hotel in Texas, and the trend for corporate travel.